$HURN

Huron Consulting Group Shares Soar 32% After Blowout Earnings Beat and Raised Full-Year Guidance Today

Huron Consulting Group (Huron) shares rose 32.11% to $160.34 after the firm reported Q2 adjusted EPS of $2.46 vs $2.17 expected and revenue of $475.0 million vs about $449 million expected. Huron raised 2026 guidance to revenue before reimbursable expenses of $1.85B-$1.89B and adjusted EPS of $9.00-$9.40, citing AI work and acquisitions including RelateCare.

Original reporting
Published Jul 29, 2026, 4:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 4:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Huron Consulting Group Shares Soar 32% After Blowout Earnings Beat and Raised Full-Year Guidance Today — source image
Decision brief

The 30-second read

$HURNBullishHigh
01

Why it matters

The article provides a fresh earnings and guidance catalyst, including quantified AI bookings mix growth and RelateCare’s expected 2026 revenue and EPS contribution, which can materially shift forward earnings expectations.

02

Market read

This is a same-cycle earnings and guidance reset for HURN, with AI bookings mix and acquisition contribution explicitly tied to the raised outlook.

03

What to watch

Traders may be underweighting execution risk around RelateCare integration timing and whether digital/AI bookings growth sustains at the same rate into subsequent quarters.

Relevance 9/10Novelty 9/10Timing: after-hours earnings release Tuesday, with guidance update driving Wednesday morning trading

Background

Huron is a professional services consulting firm with healthcare, education, and commercial segments, increasingly emphasizing digital and AI-related work.

Company-level read

Ticker impact

$HURNBullishHigh confidence
Context

Huron reported Q2 adjusted EPS of $2.46 vs $2.17 expected and raised FY guidance, driving a 32% stock surge.

Expected impact

Near-term volatility likely remains elevated as traders reassess the durability of AI-led bookings and the pace of RelateCare contribution versus the raised guidance.

Evidence & confidence

The article discloses specific Q2 results, expanded guidance ranges, and quantified AI bookings mix and RelateCare 2026 contribution, all of which can change forward estimates immediately.

Market effects

A strong AI-services read-through could support sentiment for other professional services firms with digital/AI consulting exposure, though the article is single-name focused.

Primarily US-focused impact via a Chicago-based large-cap professional services name.

Limited direct global spillover; relevance is mainly for US consulting and AI-enabled services demand expectations.

Counterpoint

The stock’s move may over-discount a single quarter’s strength, and the AI bookings mix shift could prove less repeatable than the guidance implies.

Key entities

  • Huron Consulting Group

    Reported Q2 adjusted EPS and revenue above consensus and raised full-year 2026 guidance; stock surged 32% in Wednesday trading.

  • RelateCare

    AI-enabled clinical and patient-access managed services provider acquired June 3; expected to contribute about $30M revenue before reimbursable expenses and about $0.10 adjusted EPS in 2026.

  • John Kelly

    CFO cited the guidance midpoint implying ~17% growth over 2025 results.

  • C. Mark Hussey

    CEO attributed growth to AI-related work and digital services momentum.

Related articles

$HURNMedAI 8/10

5 Insightful Analyst Questions From Huron’s Q2 Earnings Call

Huron reported Q2 CY2026 revenue of $475M vs $460.4M estimates, and adjusted EPS of $2.46 vs $2.17, with adjusted EBITDA of $72.64M. The company raised full-year guidance to $1.87B revenue and $9.20 adjusted EPS midpoint. Management attributed growth to AI-enabled solutions and managed services expansion, including outcome-based contracts.

$HURNMedAI 8/10

Huron Consulting Group Inc. Q2 2026 Earnings Call Summary

Strategic Performance Drivers Achieved record RBR growth of 16% driven by strong organic performance across all three segments and a meaningful step-up in digital capabilities. Healthcare segment growth of 17% was fueled by persistent financial challenges for providers, including rising labor and supply costs that outpace reimbursements.

$HURNHighAI 9/10

Why Is Huron (HURN) Stock Soaring Today

Huron Consulting Group (HURN) shares rose 35.8% after the company reported Q2 results that beat analyst expectations and lifted its full-year outlook. Revenue was $475M, up 15.4% YoY versus $449M consensus. Adjusted EPS was $2.46 versus $2.17 forecast. Huron raised full-year revenue guidance to $1.87B midpoint and adjusted EPS to $9.20.

$HURNMedAI 8/10

Huron (NASDAQ:HURN) Reports Strong Q2 CY2026, Full

Huron Consulting Group (HURN) reported Q2 CY2026 results. Revenue rose 15.4% year over year to $475 million, exceeding market estimates. Full-year revenue guidance midpoint was $1.87 billion, 2.4% above analysts’ expectations. Non-GAAP EPS was $2.46, 13.2% above consensus. Adjusted operating margin rose to 13.3% in Q2.

$HURNHigh

Huron Consulting Group Inc. (HURN): Results of Operations and Financial Condition

Huron Consulting Group Inc. (HURN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 hurn2026630exh991.htm EX-99.1 Document Exhibit 99.1 NEWS MEDIA CONTACT Allie Bovis FOR IMMEDIATE RELEASE abovis@hcg.com INVESTOR CONTACT John D. Kelly investor@hcg.com Huron Announces Record Second Quarter 2026 Financial Results and Increases 2026 Guidance SECOND QUARTE

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.